OZEMPIC SEMAGLUTIDE 0.5MG INJECTION 1`S
Ozempic????? is a once-weekly subcutaneous injection containing Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist indicated for glycemic control in type 2 diabetes mellitus. It works by enhancing insulin secretion in response to elevated blood glucose, suppressing glucagon release, and delaying gastric emptying ?????? all contributing to improved glycemic control and potential weight loss. Ozempic has also shown cardiovascular benefits in patients with type 2 diabetes and established cardiovascular disease. It is not insulin and is not indicated for type 1 diabetes or diabetic ketoacidosis. Ozempic is available in various dosing strengths to allow flexible titration. What is type 2 diabetes? Type 2 diabetes is a condition in which your body does not make enough insulin, and the insulin that your body makes does not lower your blood sugar the way it should. In some cases, your body can produce too much blood sugar. If your blood sugar increases and remains high over a long period of time, this can lead to harmful effects such as heart problems, kidney disease, eye disorders and poor circulation in your limbs. That is why it is important to keep your blood sugar levels within a normal range.
KES 68,642.00
(Inclusive of all taxes)
-
No Warranty
-
COD Avilable
-
Non Returnable
-
Non cancelable
About this item
Brand Name: La Roche
OZEMPIC SEMAGLUTIDE 0.5MG INJECTION 1`S